ERBB3 influences PI3K/AKT/mTOR pathway activation and epithelial−mesenchymal transition (EMT) in CC (45–47), contributing to immune evasion and tumor development, and may interact with immune checkpoints to facilitate tumor escape (48–54). This evidence concerns the gene ERBB3 and neoplasm.